Gastroenterology

Preemptive DAAs for HCV+ Donor Livers Found Cost Effective

(MedPage Today) — Direct-acting antiviral therapy in seronegative liver recipients could shorten transplant waiting lists

Source link

Related posts

Human-gut-microbiome on a chip

Newsemia

Health Tip: Prevent Bloating

Newsemia

AMA Aims to Boost Affordability of ACA Marketplace Plans

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World